Jens scholz. jensscholz


Major Jens Scholz, Member, Advisory Board at HSH Nordbank AG
  • Homer Another aspect, that i understand now is, how it could happen, that an extensive image campaign completely misses its goal. I was asked what says that makes all the german bloggers talk about , and this guy.
13.05.2020
Claudio Jens Scholz profile
  • Brice By the way: Sebastian Thurner finds the campaign simply wrong.
  • Arnulfo The Presence of Jens Scholz's profile does not indicate a business or promotional relationship of any kind between RelSci and Jens Scholz.
05.03.2020
Heather Jens Scholz Inventions, Patents and Patent Applications
  • Ulysses There are no data protection regulations related to limited company data and no authorisations or permissions required with regards to its publication. Weblogs, the toilet walls of the internet.
13.04.2020
Noel SCHOLZ .. jens scholz .. .. .. ihr menschen seid komisch ..
  • Gail Our fellow advertisers, busily piping up in trade journals.
25.04.2020
Jamar Jens Scholz e.K., Göttingen
  • Chang Abstract: The present invention relates to a method of producing a liquid biopharmaceutical drug product, comprising a biomolecule of interest, the method comprising: a a first phase of preparing a drug substance of the biomolecule of interest, said first phase comprising at least one processing step selected from a1 harvesting, a2 purification, a3 re-buffering, and a4 enrichment, wherein said at least one processing step in this first phase is carried out in the presence of a composition comprising at least three amino acids, wherein the combination of said at least three amino acids provides at least one positively charged functional group, at least one anti-oxidative functional group, at least one osmolytic function, and at least one buffering function, and b a second phase of further processing the drug substance prepared in a to obtain a liquid biopharmaceutical drug product, said second phase comprising at least one processing step selected from b1 re-buffering, b2 freezing, b3 thawing, and b Abstract: The present invention relates to a method of producing a biopharmaceutical drug product comprising a biomolecule of interest, the method comprising: a a first phase of preparing a drug substance of the biomolecule of interest, said first phase comprising at least one processing step selected from a1 harvesting, a2 purification, a3 re-buffering, and a4 enrichment, wherein said at least one processing step in this first phase is carried out in the presence of a composition comprising at least three amino acids, wherein the combination of said at least three amino acids provides at least one positively charged functional group, at least one anti-oxidative functional group, at least one osmolytic function, and at least one buffering function, and b a second phase of further processing the drug substance prepared in a to obtain a biopharmaceutical drug product, said second phase comprising at least one processing step selected from b1 re-buffering, b2 freezing, b3 thawing, and b4 filling; whe Abstract: The present invention relates to a method of producing low viscous and highly concentrated biopharmaceutical drug products comprising a biomolecule of interest, the method comprising: a a first phase of preparing a drug substance of the biomolecule of interest, said first phase comprising at least one processing step selected from a1 harvesting, a2 purification, a3 re-buffering, and a4 enrichment, wherein said at least one processing step in this first phase is carried out in the presence of a composition comprising at least three amino acids, wherein the combination of said at least three amino acids provides at least one positively charged functional group, at least one anti-oxidative functional group, at least one osmolytic function, and at least one buffering function, and b a second phase of further processing the drug substance prepared in a to obtain a low viscous and highly concentrated biopharmaceutical drug product, said second phase comprising at least one processing step selected fro Abstract: Examples are provided for device access control.
06.05.2020
Thad Jens Scholz profile
  • Kyle I only just realized again how right she was. And most bloggers really just exude.
  • Rickie The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder.
21.03.2020
Micheal Jens Scholz e.K., Göttingen
  • Kelly Even after watching it fifty times I still feel touched, even moved - although I am not even Germany.
01.03.2020
Matt Jens Scholz profile
  • Luke In one example, a computing device to which access is controlled includes a display device for presenting a user interface, a processor, and a storage device storing instructions executable by the processor to, for each of a threshold number of rounds, display a plurality of candidate regions, each candidate region including a plurality of candidate authentication objects, and receive input indicating a device access control response.
06.04.2020
Jarrett SCHOLZ .. jens scholz .. .. .. ihr menschen seid komisch ..
  • Alphonse Yours, Jean-RemyThere are - as can be seen in the great diversity of the reactions in the other blogs - lots of issues in this. With such a distorted perspective the fall is a matter of time: Jean-Remy von Matt aimed so low, that he eventually shot his foot.
18.05.2020